• citations in SCIndeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[]
  • visits in previous 30 days:17
  • full-text downloads in 30 days:12


article: 9 from 1714  
Back back to result list
2021, vol. 2, iss. 3, pp. 236-247
COVID-19 mortality in Belgrade
aGradski zavod za javno zdravlje Beograd, Beograd
bUniverzitet u Beeogradu, Medicinski fakultet, Institut za socijalnu medicinu, Centar-Škola javnog zdravlja i zdravstvenog menadžmenta, Beograd
Introduction: Mortality data are the most reliable indicators of the number of lives that a community has lost due to COVID-19 and represent the minimum data necessary for public health decision-making. Aim: The aim of the study is to describe the basic characteristics of population mortality from COVID-19 in Belgrade in 2020. Methods: The unit of observation in this cross-sectional study for the description of mortality from COVID-19 in 2020 was the population of Belgrade (total, by sex, and by age intervals). COVID-19 was analyzed as the main cause of death (ICD-10: U071, U072). The number and the structure of deaths (%), the crude death rate (per 1,000 population) and the specific death rate (per 100,000 population) were analyzed. The data sources for the study were official statistics on vital events of the Statistical Office of the Republic of Serbia. Results: In 2020, 10.5% of the total number of deaths were due to COVID-19, and the majority of deaths was from the male contingent of Belgrade residents. The mortality rate due to COVID-19 was 158.78 per 100,000 population (211.7 for males and 111.4 for females). COVID-19 was the second leading cause of death in Belgrade. Conclusion: The results of this study indicate the existence of premature mortality in Belgrade. In 2020, COVID-19 was the second leading cause of death among the male residents of Belgrade, while in female residents, it was the third leading cause of mortality. This research provides evidence that can contribute to the international discussion about societal losses caused by the COVID-19 pandemic.
*** Stanovništvo - elektronska baza podataka. Republika Srbija-Republički zavod za statistiku Srbije,
*** (2020) WHO Director-General's opening remarks at the media briefing on COVID-19. March; [Accessed on 8 August 2021], Available on: https://
*** (2021) Vitalni događaji 2020. Republika Srbija-Republički zavod za statistiku, Saopštenje SN 40; 180; [Internet]: [Accessed on 4 September 2021], Available on:
*** WHO coronavirus (COVID-19) dashboard. [Accessed on 4 September 2021]. Available on:
*** Međunarodne smernice za potvrđivanje i klasifikaciju (šifriranje) KOVID-19 kao uzroka smrti. [Accessed on 9 August 2021]. Available on: https:// 9
Abraído-Lanza, A.F., Dohrenwend, B.P., Ng-Mak, D.S., Turner, J.B. (1999) The Latino mortality paradox: A test of the 'salmon bias' and healthy migrant hypotheses. American Journal of Public Health, 89(10): 1543-1548
Adam, K. Second wave of Covid-19 in Europe leads to new restrictions but no national lockdowns. [Internet]
Barone, E. (2021) Why some people are waiting weeks for their COVID-19 test results. Time, [Published 12 October], [Accessed on 9 August 2021]
Beaumont, P. (2020) Coronavirus testing: How some countries got ahead of the rest. Guardian, apr/02/coronavirus-testing-how-some-countries-germany-south-koreagot-ahead-of-the-rest,[Published 2 April]. [Accessed on 9 August 2021]
Bell, D., Schultz Hansen, K., Kiragga, A.N., Kambugu, A., Kissa, J., Mbonye, A.K. (2020) Predicting the impact of COVID-19 and the potential impact of the public health response on disease burden in Uganda. American Journal of Tropical Medicine and Hygiene, u štampi
Bennhold, K.A. (2020) German exception: Why the country's coronavirus death rate is low. New York Times, [Published 4 April], [Accessed on 9 August 2021]
Brooks, J.T., Butler, J.C. (2021) Effectiveness of mask wearing to control community spread of SARS-CoV-2. JAMA, 325(10): 998
Chan, J.F., Yuan, S., Kok, K.H., To, K.K.W., Chu, H., Yang, J., et al. (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet, 95: 514-523
COVID-19 Prevention Network [Accessed on 9 August 2021]. Available on:
Doroshenko, A. (2021) The combined effect of vaccination and nonpharmaceutical public health interventions-ending the COVID-19 pandemic. JAMA Network Open, 4(6): e2111675
European Centre for Disease Prevention and Control Prevention and control of COVID-19. [Accessed on 9 August 2021]. Available on: https:// covid-19/prevention-and-control-covid-19]
Fan, C., Fann, J.C., Yang, M., Lin, T., et al. (2021) Estimating global burden of COVID-19 with disability-adjusted life years and value of statistical life metrics. Journal of the Formosan Medical Association, S0929-6646(21)00234-5
Gémes, K., Talbäck, M., Modig, K., Ahlbom, A., Berglund, A., Feychting, M., et al. (2020) Burden and prevalence of prognostic factors for severe covid-19 disease in Sweden. Eur J Epidemiol, 35(5):401-409
He, M., Li, X., Tan, Q., Chen, Y., Kong, Y., You, J., et al. (2021) Disease burden from COVID-19 symptoms among inpatients at the temporary military hospitals in Wuhan: A retrospective multicentre cross-sectional study. BMJ Open, 11(5): e048822
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497-506; [Erratum in: Lancet. 2020 Jan 30;]
Institut za javno zdravlje Srbije Dr Milan Jovanović Batut, World Health Organization (2010) Međunarodna statistička klasifikacija bolesti i srodnih zdravstvenih problema - 10. revizija - knjiga 2 - priručnik za upotrebu. Beograd
Jo, M., Go, D., Kim, R., Lee, S.W., Ock, M., Kim, Y., et al. (2020) The burden of disease due to COVID-19 in Korea using disability-adjusted life years. Journal of Korean Medical Science, 35(21): e199
John, D., Narassima, M.S., Menon, J., Rajesh, J.G., Banerjee, A. (2021) Estimation of the economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala, India: A model-based analysis. BMJ Open, 11(8): e049619
Kupferschmidt, K., Cohen, J. (2020) Will novel virus go pandemic or be contained?. Science, 367(6478): 610-611
Lagerweij, G., Schimmer, B., Mooij, S., Raven, S., Schoffelen, A., de Gier, B., et al. State of infectious diseases in the Netherlands, 2019. RIVM-Rapport 2020-0048
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. (2020) Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine, 382(13): 1199-1207
Linton, N.M., Kobayashi, T., Yang, Y., Hayashi, K., Akhmetzhanov, A.R., Jung, S., et al. (2020) Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: A statistical analysis of publicly available case data. Journal of Clinical Medicine, 9(2): 538; Feb
Maria, N., Rapicavoli, R.V., Alaimo, S., Bischof, E., Stasuzzo, A., Broek, J., et al. (2021) Rapid identification of druggable targets and the power of the phenotype simulator for effective drug repurposing in COVID-19. Res Sq,; [Preprint]
Mishra, D., Maurya, R.R., Kumar, K., Munjal, N.S., Bahadur, V., Sharma, S., et al. (2021) Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies. Journal of Molecular Liquids, 335: 116185
Mitra, A.K., Payton, M., Kabir, N., Whitehead, A., Ragland, K.N., Brown, A. (2020) Potential Years of Life Lost due to COVID-19 in the United States, Italy, and Germany: An old formula with newer ideas. International Journal of Environmental Research and Public Health, 17(12): 4392
Nurchis, M.C., Pascucci, D., Sapienza, M., Villani, L., D'Ambrosio, F., Castrini, F., et al. (2020) Impact of the burden of COVID-19 in Italy: Results of disability-adjusted life years (DALYs) and productivity loss. International Journal of Environmental Research and Public Health, 17(12): 4233
Oh, I., Ock, M., Jang, S.Y., Go, D., Kim, Y., Jung, Y., et al. (2020) Years of life lost attributable to COVID-19 in high-incidence countries. Journal of Korean Medical Science, 35(32): e300
Ortiz-Prado, E., Simbaña-Rivera, K., Barreno, L.G., Diaz, A.M., Barreto, A., Moyano, C., et al. (2020) Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador. PLOS Neglected Tropical Diseases, 15(1): e0008958
Pifarré, I.H., Acosta, E., López-Casasnovas, G., Lo, A., Nicodemo, C., Riffe, T., et al. (2021) Years of life lost to COVID-19 in 81 countries. Scientific Reports, 11(1): 3504
Quast, T., Andel, R., Gregory, S., Storch, E.A. (2021) Years of life lost associated with COVID-19 deaths in the USA during the first year of the pandemic. Journal of Public Health, u štampi
Rommel, A., von der Lippe, E., Plass, D., Ziese, T., Diercke, M., Der, H.A.M., et al. (2021) The COVID-19 disease burden in Germany in 2020-years of life lost to death and disease over the course of the pandemic. Deutsches Aerzteblatt Online, 118
Ruiz, J.M., Steffen, P., Smith, T.B. (2013) Hispanic mortality paradox: A systematic review and meta-analysis of the longitudinal literature. American Journal of Public Health, 103(3): e52-e60
Salinas-Escudero, G., Toledano-Toledano, F., García-Peña, C., Parra-Rodríguez, L., Granados-García, V., Carrillo-Vega, M.F. (2021) Disability-adjusted life years for the COVID-19 pandemic in the Mexican population. Frontiers in Public Health, 9:686700
Soneji, S., Beltrán-Sánchez, H., Yang, J.W., Mann, C. (2021) Population-level mortality burden from novel coronavirus (COVID-19) in Europe and North America. Genus, 77: 7
Tchole, A.I.M., Li, Z., Wei, J., Ye, R., Wang, W., Du, W., et al. (2020) Epidemic and control of COVID-19 in Niger: Quantitative analyses in a least developed country. Journal of Global Health, 10(2): 20513
The Institute for Health Metrics and Evaluation (2021) Estimation of the excess mortality due to COVID-19. node/8660. Objavljeno 13. 5
Vasishtha, G., Mohanty, S.K., Mishra, U.S., Dubey, M., Sahoo, U. (2021) Impact of COVID-19 infection on life expectancy, premature mortality, and DALY in Maharashtra, India. BMC Infectious Diseases, 21(1): 343
Woolf, S.H., Chapman, D.A., Lee, J.H. (2021) COVID-19 as the leading cause of death in the United States. JAMA, 325: 123-124
World Health Organization The top 10 causes of death. [Pristupljeno 09.08.2021.]
Wright, A., Salazar, A., Mirica, M., Volk, L.A., Schiff, G.D. (2020) The invisible epidemic: Neglected chronic disease management during COVID-19. Journal of General Internal Medicine, 35(9): 2816-2817
Wyper, G.M.A., Assunção, R., Cuschieri, S., Devleesschauwer, B., Fletcher, E., Haagsma, J.A., et al. (2020) Population vulnerability to COVID-19 in Europe: A burden of disease analysis. Archives of Public Health, 78, 47
Yi-Hsuan, C., Chi-Tai, F., Yu-Ling, H. (2020) Effect of non-lockdown social distancing and testing-contact tracing during a COVID-19 outbreak in Daegu, South Korea. Int J Infect Dis, 110: 213-221
Zhao, J., Jin, H., Li, X., Jia, J., Zhang, C., Zhao, H., et al. (2021) Disease burden attributable to the first wave of COVID-19 in China and the effect of timing on the cost-effectiveness of movement restriction policies. Value in Health, u štampi


article language: Serbian, English
document type: Original Paper
DOI: 10.5937/smclk2-33540
received: 13/08/2021
revised: 14/09/2021
accepted: 15/09/2021
published online: 30/09/2021
published in SCIndeks: 15/10/2021

Related records

Praxis medica (2021)
Respiratory epithelium: Place of entry and / or defense against SARS-CoV-2 virus
Leštarević Snežana, et al.

Arhiv za farmaciju (2020)
Anti-dementia medications: Fighting a losing battle?
Micov Ana, et al.

Hrana i ishrana (2020)
Vitamin C biochemistry: From scurvy to COVID-19 treatment
Zakić Tamara, et al.

show all [9]